Fermenta Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	282.4	218.29	352.91	130.56	167.94
Short-Term Investments	-	424.2	379.95	247.68	126.37	195.73
Cash & Short-Term Investments	518.66	706.59	598.24	600.59	256.93	363.67
Cash Growth	40.74%	18.11%	-0.39%	133.75%	-29.35%	168.82%
Accounts Receivable	-	1,041	729.75	448.69	870.9	680.15
Other Receivables	-	153.18	9.39	3.51	79.03	106.04
Receivables	-	1,205	785.78	462.45	950.08	833.85
Inventory	-	1,329	890.75	1,312	1,733	1,709
Prepaid Expenses	-	23.27	51.7	26.77	27.85	21.67
Restricted Cash	-	-	0	3.84	0.13	0.09
Other Current Assets	-	88.96	91.07	125.02	172.01	168.3
Total Current Assets	-	3,352	2,418	2,530	3,140	3,096
Property, Plant & Equipment	-	2,322	2,535	2,585	2,373	2,194
Long-Term Investments	-	4.86	4.43	3.76	48.93	2.49
Goodwill	-	41.17	41.17	115.3	109.55	107.14
Other Intangible Assets	-	29.98	71.55	132.72	175.95	210.09
Long-Term Deferred Tax Assets	-	286.44	219.99	332.58	359.94	403.1
Long-Term Deferred Charges	-	0.82	1.15	-	0.16	0.5
Other Long-Term Assets	-	105.38	184.8	664.14	860.34	856.93
Total Assets	-	6,145	5,478	6,365	7,068	6,871
Accounts Payable	-	774.87	649.04	457.95	645.8	621.37
Accrued Expenses	-	49.94	81.86	40	68.96	100.92
Short-Term Debt	-	812.4	673.42	1,015	974.75	963
Current Portion of Long-Term Debt	-	131.13	223.93	318	239.88	225.86
Current Portion of Leases	-	10.92	9.58	6.87	10.7	11.62
Current Income Taxes Payable	-	44.11	3.41	3.25	3.2	3.2
Current Unearned Revenue	-	190.09	3	0.95	-	-
Other Current Liabilities	-	105.31	88.36	245.6	127.94	167.37
Total Current Liabilities	-	2,119	1,733	2,087	2,071	2,093
Long-Term Debt	-	150.48	425.36	835.89	1,147	1,104
Long-Term Leases	-	44.44	55.39	19.91	19.68	17
Pension & Post-Retirement Benefits	-	41.38	25.62	21.43	18.85	12.74
Other Long-Term Liabilities	-	204.54	387.7	275.1	97.32	40.36
Total Liabilities	-	2,560	2,627	3,240	3,354	3,268
Common Stock	-	145.85	144.37	144.29	144.24	144.24
Additional Paid-In Capital	-	171.23	23.69	15.28	-	-
Retained Earnings	-	3,628	2,903	3,169	3,618	3,538
Comprehensive Income & Other	-	-318.36	-182.93	-174.98	-41.28	-76.73
Total Common Equity	3,908	3,627	2,889	3,153	3,721	3,606
Minority Interest	-	-41.57	-36.98	-27.49	-6.83	-2.96
Shareholders' Equity	3,855	3,585	2,852	3,126	3,715	3,603
Total Liabilities & Equity	-	6,145	5,478	6,365	7,068	6,871
Total Debt	1,119	1,149	1,388	2,195	2,392	2,322
Net Cash (Debt)	-600.33	-442.76	-789.44	-1,595	-2,135	-1,958
Net Cash Per Share	-20.39	-15.18	-27.34	-55.26	-73.61	-67.51
Filing Date Shares Outstanding	29.08	29.43	29.43	28.86	28.85	28.85
Total Common Shares Outstanding	29.08	29.43	29.43	28.86	28.85	28.85
Working Capital	-	1,234	684.93	443.05	1,069	1,003
Book Value Per Share	134.13	123.23	98.15	109.27	129.00	125.00
Tangible Book Value	3,843	3,556	2,776	2,905	3,436	3,289
Tangible Book Value Per Share	131.92	120.81	94.32	100.67	119.10	114.00
Land	-	3.43	3.43	3.43	3.43	3.43
Buildings	-	1,010	1,007	717.57	701.21	564.73
Machinery	-	2,140	2,101	1,892	1,799	1,379
Construction In Progress	-	159.07	16.16	419.03	298.93	527.01
Leasehold Improvements	-	59.13	211.64	211.64	49.86	44.75

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.